Brief: Casi Pharmaceuticals Appointed Cnmc As Sole Distributor For Sale Of Pralatrexate
08/12/2023 21:21
Dec 9 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS INC - ON DECEMBER 6, CO ENTERED INTO
AN
EXCLUSIVE DISTRIBUTION AGREEMENT WITH CHINA NATIONAL MEDICINES
CORPORATION LTD.
* CASI PHARMACEUTICALS- APPOINTED CNMC AS SOLE DISTRIBUTOR
FOR
SALE OF PRALATREXATE FOR INJECTION IN TERRITORY OF PEOPLE S
REPUBLIC OF CHINA FOR 1 YEAR
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary